Download PDF
J Neurol Surg B Skull Base 2019; 80(02): 209-213
DOI: 10.1055/s-0039-1679890
Invited Review
Georg Thieme Verlag KG Stuttgart · New York

Temporal Bone Paraganglioma: Hearing Outcomes and Rehabilitation

David D. Walker
1   Department of Neurotology, Michigan Ear Institute, Farmington Hills, Michigan, United States
,
Seilesh Babu
1   Department of Neurotology, Michigan Ear Institute, Farmington Hills, Michigan, United States
› Author Affiliations
Further Information

Publication History

05 June 2018

31 December 2018

Publication Date:
14 February 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Despite numerous advancements in the treatment of skull base tumors, the management of jugular paragangliomas remains controversial and nuanced. Contemporary treatment objectives focus not only on achieving durable tumor control but also on maximizing post-treatment quality of life. While this philosophy places appropriate attention on limiting cranial neuropathies, less discussed morbidities such as hearing loss can have a profound impact on quality of life outcomes. The objective of this retrospective review is to provide a comprehensive review of hearing outcomes following the treatment of tympanojugular paragangliomas. A particular focus is placed on the variable audiologic outcomes as it relates to disease pathology, extent of disease, as well as chosen treatment modality. This review underscores the importance of considering treatment-related effects on hearing.

Keywords

paraganglioma - glomus tympanicum - hearing outcomes - stereotactic radiosurgery
 

  • References

  • 1 Rosenwaser H. Carotid body tumor of the middle ear and mastoid. Arch Otolaryngol 1945; 41 (01) 64-67
    CrossrefPubMedGoogle Scholar
  • 2 Cheesman AD, Kelly AM. Rehabilitation after treatment for jugular foramen lesions. Skull Base 2009; 19 (01) 99-108
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Neskey DM, Hatoum G, Modh R. , et al. Outcomes after surgical resection of head and neck paragangliomas: a review of 61 patients. Skull Base 2011; 21 (03) 171-176
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Tufarelli D, Meli A, Alesii A. , et al. Quality of life after acoustic neuroma surgery. Otol Neurotol 2006; 27 (03) 403-409
    CrossrefPubMedGoogle Scholar
  • 5 Patnaik U, Prasad SC, Medina M. , et al. Long term surgical and hearing outcomes in the management of tympanomastoid paragangliomas. Am J Otolaryngol 2015; 36 (03) 382-389
    CrossrefPubMedGoogle Scholar
  • 6 Forest III JA, Jackson CG, McGrew BM. Long-term control of surgically treated glomus tympanicum tumors. Otol Neurotol 2001; 22 (02) 232-236
    CrossrefPubMedGoogle Scholar
  • 7 Liscak R, Urgosik D, Chytka T. , et al. Leksell Gamma Knife radiosurgery of the jugulotympanic glomus tumor: long-term results. J Neurosurg 2014; 121 (Suppl): 198-202
    CrossrefPubMedGoogle Scholar
  • 8 Sanna M, Jain Y, De Donato G, , Rohit, Lauda L, Taibah A. Management of jugular paragangliomas: the Gruppo Otologico experience. Otol Neurotol 2004; 25 (05) 797-804
    CrossrefPubMedGoogle Scholar
  • 9 House WF, Hitselberger WE. The transcochlear approach to the skull base. Arch Otolaryngol 1976; 102 (06) 334-342
    CrossrefPubMedGoogle Scholar
  • 10 Fisch U. Infratemporal fossa approach to tumours of the temporal bone and base of the skull. J Laryngol Otol 1978; 92 (11) 949-967
    CrossrefPubMedGoogle Scholar
  • 11 Jackson CG, Haynes DS, Walker PA, Glasscock III MEIII, Storper IS, Josey AF. Hearing conservation in surgery for glomus jugulare tumors. Am J Otol 1996; 17 (03) 425-437
    PubMedGoogle Scholar
  • 12 Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R. Radiotherapy-induced ear toxicity. Cancer Treat Rev 2003; 29 (05) 417-430
    CrossrefPubMedGoogle Scholar
  • 13 Patel NS, Link MJ, Driscoll CLW, Pollock BE, Lohse CM, Carlson ML. Hearing outcomes after stereotactic radiosurgery for jugular paraganglioma. Otol Neurotol 2018; 39 (01) 99-105
    CrossrefPubMedGoogle Scholar
  • 14 Dobberpuhl MR, Maxwell S, Feddock J, St Clair W, Bush ML. Treatment outcomes for single modality management of glomus jugulare tumors with stereotactic radiosurgery. Otol Neurotol 2016; 37 (09) 1406-1410
    CrossrefPubMedGoogle Scholar
  • 15 Selivanova O, Gouveris H, Mann W. Cochlear implantation after surgery for bilateral jugular foramen paragangliomas: a case report. Eur Arch Otorhinolaryngol 2009; 266 (03) 463-464
    CrossrefPubMedGoogle Scholar
  • 16 Pisa J, Sulkers J, Butler JB, West M, Hochman JB. Stereotactic radiosurgery does not appear to impact cochlear implant performance in patients with neurofibromatosis type II. J Radiosurg SBRT 2017; 5 (01) 63-71
    PubMedGoogle Scholar
  • 17 Costello MS, Golub JS, Barrord JV, Pater L, Pensak ML, Samy RN. Cochlear implantation after radiation therapy for acoustic neuroma. J Radiosurg SBRT 2016; 4 (01) 69-74
    PubMedGoogle Scholar
  • 18 Medina MdelM, Piccirillo E, D'orazio F, Bacciu A, Guida M, Sanna M. Cochlear implantation in irradiated tympanojugular paraganglioma. Int J Audiol 2015; 54 (12) 987-990
    CrossrefPubMedGoogle Scholar
  • 19 Crane BT, Gottschalk B, Kraut M, Aygun N, Niparko JK. Magnetic resonance imaging at 1.5 T after cochlear implantation. Otol Neurotol 2010; 31 (08) 1215-1220
    CrossrefPubMedGoogle Scholar